Droperidol and Adenoidal hypertrophy - a phase IV clinical study of FDA data


Adenoidal hypertrophy is reported only by a few people who take Droperidol.

The phase IV clinical study analyzes which people take Droperidol and have Adenoidal hypertrophy. It is created by eHealthMe based on reports of 2,189 people who have side effects while taking Droperidol from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

2,189 people reported to have side effects when taking Droperidol.
Among them, 2 people (0.09%) have Adenoidal hypertrophy.

What is Droperidol?

Droperidol has active ingredients of droperidol. eHealthMe is studying from 2,194 Droperidol users for its effectiveness, alternative drugs and more.

What is Adenoidal hypertrophy?

Adenoidal hypertrophy (enlarged adenoids) is found to be associated with 230 drugs and 120 conditions by eHealthMe.

Number of Droperidol and Adenoidal hypertrophy reports submitted per year:

Could Droperidol cause Adenoidal hypertrophy?

Gender of people who have Adenoidal hypertrophy when taking Droperidol *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Adenoidal hypertrophy when taking Droperidol *:

  • 0-1: 0.0 %
  • 2-9: 100 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Droperidol *:

  1. Propofol: 2 people, 100.00%
  2. Fentanyl Citrate: 2 people, 100.00%
  3. Atropine: 2 people, 100.00%
  4. Sevoflurane: 1 person, 50.00%
  5. Genotropin: 1 person, 50.00%

Common side effects people have besides Adenoidal hypertrophy *:

  1. Sleep Apnea Syndrome: 2 people, 100.00%
  2. Disease Progression: 2 people, 100.00%
  3. Tonsillar Hypertrophy (enlargement of the tonsils): 1 person, 50.00%
  4. Respiratory Disorder (respiratory disease): 1 person, 50.00%
  5. Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Droperidol and have Adenoidal hypertrophy?

Check whether Adenoidal hypertrophy is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Adenoidal hypertrophy and when was it recovered:

Expand to all the drugs that have ingredients of droperidol:

Alternative drugs to, pros and cons of Droperidol:

Common Droperidol side effects:

Browse all side effects of Droperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Adenoidal hypertrophy treatments and more:

COVID vaccines that are related to Adenoidal hypertrophy:

All the drugs that are associated with Adenoidal hypertrophy:

All the conditions that are associated with Adenoidal hypertrophy:

How the study uses the data?

The study uses data from the FDA. It is based on droperidol (the active ingredients of Droperidol) and Droperidol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: